Ignite Creation Date:
2025-12-24 @ 7:55 PM
Ignite Modification Date:
2026-03-28 @ 3:46 AM
Study NCT ID:
NCT02411604
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2016-01-20
First Post:
2015-04-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Study for Renal Transplant Patients With Envarsus XR ™
Sponsor:
Veloxis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Envarsus® 3007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None